Related Experiment Video
Updated: Oct 31, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
CRY2 missense mutations suppress P53 and enhance cell growth
Alanna B Chan1, Gian Carlo G Parico2, Jennifer L Fribourgh2
1Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Abstract:
Disruption of circadian rhythms increases the risk of several types of cancer. Mammalian cryptochromes (CRY1 and CRY2) are circadian transcriptional repressors that are related to DNA-repair enzymes. While CRYs lack DNA-repair activity, they modulate the transcriptional response to DNA damage, and CRY2 can promote SKP1 cullin 1-F-box (SCF)FBXL3-mediated ubiquitination of c-MYC and other targets. Here, we characterize five mutations in CRY2 observed in human cancers in The Cancer Genome Atlas. We demonstrate that two orthologous mutations of mouse CRY2 (D325H and S510L) accelerate the growth of primary mouse fibroblasts expressing high levels of c-MYC. Neither mutant affects steady-state levels of overexpressed c-MYC, and they have divergent impacts on circadian rhythms and on the ability of CRY2 to interact with SCFFBXL3 Unexpectedly, stable expression of either CRY2 D325H or of CRY2 S510L robustly suppresses P53 target-gene expression, suggesting that this may be a primary mechanism by which they influence cell growth.
Insights
Mutations in CRY2, a protein regulating circadian rhythms, can accelerate cancer growth by suppressing P53 target genes. These findings highlight CRY2
Area of Science:
- Molecular Biology
- Chronobiology
- Cancer Research
Background:
- Disrupted circadian rhythms are linked to increased cancer risk.
- Mammalian cryptochromes (CRY1 and CRY2) are key circadian repressors involved in DNA damage response.
- CRY2 regulates c-MYC ubiquitination via the SCFFBXL3 complex.
Purpose of the Study:
- To characterize five CRY2 mutations found in human cancers.
- To investigate the functional impact of specific CRY2 mutations (D325H and S510L) on cell growth and circadian regulation.
- To explore the mechanism by which CRY2 mutations influence cell proliferation.
Main Methods:
- Analysis of CRY2 mutations from The Cancer Genome Atlas.
- Characterization of mouse CRY2 mutations (D325H, S510L) in primary mouse fibroblasts.
- Assessment of c-MYC levels, circadian rhythm impact, and SCFFBXL3 interaction.
- Evaluation of P53 target-gene expression in cells expressing mutant CRY2.
Main Results:
- Two mouse CRY2 mutations (D325H, S510L) accelerate fibroblast growth when c-MYC is overexpressed.
- Mutant CRY2 proteins do not alter steady-state levels of overexpressed c-MYC.
- Mutants exhibit differential effects on circadian rhythms and SCFFBXL3 interaction.
- Both CRY2 D325H and CRY2 S510L robustly suppress P53 target-gene expression.
Conclusions:
- CRY2 mutations identified in human cancers can promote cell growth.
- Suppression of P53 target-gene expression by mutant CRY2 may be a key mechanism driving increased cell proliferation in cancer.
- CRY2's role in circadian regulation and DNA damage response is critical in cancer development.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle

